Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5942)
All Articles published online
|
Publishing Process of This Article
|
Mar 7, 2013 (publication date) through Nov 30, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kim K, Min HS, Chie EK, Jang JY, Kim SW, Han SW, Oh DY, Im SA, Kim TY, Bang YJ, Jang JJ, Ha SW. CD24 expression predicts distant metastasis in extrahepatic bile duct cancer. World J Gastroenterol 2013; 19(9): 1438-1443 [PMID: 23539485 DOI: 10.3748/wjg.v19.i9.1438] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i9/1438.htm |
| Number | Citing Articles |
| 1 |
Xin Zhou. CD24 Polymorphisms Cannot Predict Pathologic Complete Response to Anthracycline- and Taxane-Based Neoadjuvant Chemotherapy in Breast Cancer. Clinical Breast Cancer 2014; 14(2): e33 doi: 10.1016/j.clbc.2013.11.001
|
| 2 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 587 doi: 10.1007/978-3-319-26956-6_30
|
| 3 |
Shinsuke Nakashima, Shogo Kobayashi, Hiroaki Nagano, Akira Tomokuni, Yoshito Tomimaru, Tadafumi Asaoka, Naoki Hama, Hiroshi Wada, Koichi Kawamoto, Shigeru Marubashi, Hidetoshi Eguchi, Yuichiro Doki, Masaki Mori. BRCA/Fanconi anemia pathway implicates chemoresistance to gemcitabine in biliary tract cancer. Cancer Science 2015; 106(5): 584 doi: 10.1111/cas.12652
|
| 4 |
H. J. Park, K. Kim, J. H. Paik, E. K. Chie, S. Kim, J.-Y. Jang, S. W. Kim, S.-W. Han, D.-Y. Oh, S.-A. Im, T.-Y. Kim, Y.-J. Bang, S. W. Ha. Is c-Met oncoprotein expression an adverse prognosticator in extrahepatic bile duct cancer treated with curative resection followed by adjuvant chemoradiotherapy?. Clinical and Translational Oncology 2016; 18(6): 625 doi: 10.1007/s12094-015-1409-5
|
| 5 |
Maurizio Romano, Francesco De Francesco, Enrico Gringeri, Antonio Giordano, Giuseppe A. Ferraro, Marina Di Domenico, Umberto Cillo. Tumor Microenvironment Versus Cancer Stem Cells in Cholangiocarcinoma: Synergistic Effects?. Journal of Cellular Physiology 2016; 231(4): 768 doi: 10.1002/jcp.25190
|
| 6 |
Hsing-Ju Wu, Pei-Yi Chu. Role of Cancer Stem Cells in Cholangiocarcinoma and Therapeutic Implications. International Journal of Molecular Sciences 2019; 20(17): 4154 doi: 10.3390/ijms20174154
|
| 7 |
Shiran Shapira, Dina Kazanov, Rachel Dankner, Sigal Fishman, Naftali Stern, Nadir Arber. High Expression Level of PPARγ in CD24 Knockout Mice and Gender-Specific Metabolic Changes: A Model of Insulin-Sensitive Obesity. Journal of Personalized Medicine 2021; 11(1): 50 doi: 10.3390/jpm11010050
|
| 8 |
Ali Belkouz, Tim A. Labeur, Joeri Dierks, Frederike Dijk, Martijn G.H. van Oijen, Joanne Verheij, Thomas M. van Gulik, Marc J. van de Vijver, Hanneke Wilmink, Cornelis J.A. Punt, Heinz-Josef Klümpen. Prognostic immunohistochemical biomarkers of chemotherapy efficacy in biliary tract cancer: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology 2019; 141: 82 doi: 10.1016/j.critrevonc.2019.06.001
|
| 9 |
Nitish Kumar Mishra, Meng Niu, Siddesh Southekal, Prachi Bajpai, Amr Elkholy, Upender Manne, Chittibabu Guda. Identification of Prognostic Markers in Cholangiocarcinoma Using Altered DNA Methylation and Gene Expression Profiles. Frontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.522125
|
| 10 |
Yang-Hong Ni, Xia Zhao, Wei Wang. CD24, A Review of its Role in Tumor Diagnosis, Progression and Therapy. Current Gene Therapy 2020; 20(2): 109 doi: 10.2174/1566523220666200623170738
|
| 11 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_30-1
|
| 12 |
Xueyuan Cao, Donghui Cao, MeiShan Jin, Zhifang Jia, Fei Kong, Hongxi Ma, Yinping Wang, Jing Jiang. CD44 but not CD24 expression is related to poor prognosis in non-cardia adenocarcinoma of the stomach. BMC Gastroenterology 2014; 14(1) doi: 10.1186/1471-230X-14-157
|